Iodine Povacrylex

CHEMBL1201721 Phase 4 Approved Unknown
Half-Life
β€”
Bioavailability
β€”
Protein Binding
β€”
Molecular Weight
β€” g/mol
LogP
β€”
Phase
4

This iodine-releasing polymer is used as a topical antiseptic that provides sustained release of iodine to kill bacteria, fungi, and viruses on skin and wounds. Its polymer base allows for slower, more prolonged iodine release compared to standard iodine solutions.

Therapeutic Areas

Mechanism of Action

Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mechanism

Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Frequently Asked Questions

This iodine-releasing polymer is used as a topical antiseptic that provides sustained release of iodine to kill bacteria, fungi, and viruses on skin and wounds. Its polymer base allows for slower, more prolonged iodine release compared to standard iodine solutions.

Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.

Yes, Iodine Povacrylex is an approved drug. It has reached clinical phase 4. It is classified as a Unknown.

References & Data Sources

  • ChEMBL β€” European Bioinformatics Institute (EBI). CHEMBL1201721. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

Medical Disclaimer

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.